Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

44.93
Delayed Data
As of Sep 04
 +0.46 / +1.03%
Today’s Change
17.32
Today|||52-Week Range
58.73
+13.03%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close44.47
Today’s open43.89
Day’s range43.89 - 45.74
Volume331,898
Average volume (3 months)474,263
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-146.54%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio11.9
Price/Sales7.15
Price/Book5.86

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.17-0.52%
HRTXHeron Therapeutics I...+1.40+3.86%
PTCTPTC Therapeutics Inc+0.19+0.50%
FWPForward Pharma A/S-0.92-3.49%
Data as of 4:02pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

Partner Offers